General Medicine

Pr. Maslennikov (Russian winner 2019): Probiotics & cirrhosis

Research
General Medicine Gastroenterology Rheumatology

To celebrate #WorldMicrobiomeDay, Biocodex Microbiota Institute is handing the floor to national grant winners.

Lay public section

Find here your dedicated section

About this article

Created 31 May 2022
Updated 10 February 2025

Pr. Roman Maslennikov

General practitioner, gastroenterologist and rheumatologist in Moscow clinics and assistant professor at Sechenov University, Dr Maslennikov combines the teaching of internal medicine with scientific activities. His research interests are diseases of the internal organs, in particular the digestive organs and connective tissue, as well as the human microbiota. 

What has the national grant allowed to discover in your microbiota research area? 

"This grant allowed us to better understand the pathogenesis of cirrhosis and the possibility of the impact of probiotics on some links in it."1,2

What are the consequences for the patient?  

"The results of our study may show the benefit of using probiotics for the treatment of cirrhosis, which may improve the quality of life and prognosis of these patients."

Learn more
2019 Russia Grant Winner's project

Foundation's awardees

Discover other testimonies
BMI 22.14
Sources

1. Maslennikov R, Ivashkin V, Efremova I, et al. Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis. World J Hepatol. 2021 May 27;13(5):557-570.

2. Maslennikov R, Ivashkin V, Efremova I, et al. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World J Gastroenterol. 2022 Mar 14;28(10):1067-1077.

Tags
General Medicine Gastroenterology Rheumatology World Microbiome Day Cirrhosis Probiotics Research Gut microbiota Microbiome Flora

    See also

    General Medicine

    Continue reading

    News